COLUMBIA, Md., March 10, 2017 (GLOBE NEWSWIRE) -- Digital health technology leader, WellDoc®, announced today that Hope Warshaw, MMSc, RD, CDE, BC-ADM, a well-known and respected spokesperson who is passionate about improving the clinical and cost effectiveness of diabetes care and education, will join the Company in a consultative role. In this role, she will advise on further engagement with the expanding BlueStar® user base, industry advocacy groups and business partners. Additionally, she will provide social media consultation and strategy, utilizing her long-term adoption and engagement with this medium with the diabetes community. BlueStar is WellDoc’s FDA-cleared, proven digital therapeutic, which provides real-time and timely individualized coaching and support, as well as diabetes educational tools that are actionable and personal.
Ms. Warshaw also recognizes the value novel devices and technologies bring to the evolution of healthcare delivery. She has been an involved member of the diabetes community for nearly four decades, and has been a strong advocate for diabetes educators and education, as well as for individuals living with diabetes.
“Hope is a leader and advocate in the field of diabetes education, and we are excited that she is joining us as a consultant. She brings invaluable insight and counsel to our team, which already encompasses individuals who are passionate about providing solutions to improve diabetes care and self-management,” said Kevin McRaith, CEO of WellDoc. “Like many of us at WellDoc, Hope is focused on advocating for people with diabetes. Her participation alongside the WellDoc team will help ensure our users’ needs are consistently top-of-mind as we further enhance BlueStar and work to make it broadly available in the marketplace.”
Ms. Warshaw is an accomplished author, having written books and articles for publications that are centered around nutrition and diabetes. She is also the Immediate Past President of the American Association of Diabetes Educators (AADE)—joining already highly recognized diabetes educators at WellDoc including Malinda Peeples (AADE Past President) and Janice MacLeod (Former AADE Regional Chapter President).
“It’s an exciting time at WellDoc as the Company focuses on rolling out BlueStar broadly, and there are many opportunities in the area of diabetes management, community building and advocacy,” said Ms. Warshaw. “WellDoc is leading the charge in digital health to tackle type 2 diabetes by arming individuals with a robust tool to help them manage their condition to achieve significant health outcomes.”
About WellDoc®
WellDoc® is the leading digital health company revolutionizing chronic disease management to help transform lives. Our groundbreaking digital health technology is guiding individuals through the complicated journey of living with chronic diseases, with a goal of improving their health and helping them to be more balanced. We are the first digital health company based on a life science business model, and our foundation is built on randomized clinical trials that demonstrate significant clinical outcomes. We have mastered diabetes management by taking an aggressive and innovative approach that utilizes sophisticated logic and precise algorithms, and integrates the most advanced mobile technology, behavioral insight, and diabetes education for those living with type 2 diabetes. Our FDA-cleared, proven digital therapeutic, BlueStar®, provides real-time and timely individualized coaching and support, as well as diabetes educational tools that are actionable and personal. Our clinical evidence shows a 1.7 to 2.0 point A1C reduction for adults living with type 2 diabetes who used BlueStar®. For more information, visit www.WellDoc.com and www.BlueStarDiabetes.com.